Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Exercise and Neutrophil Function in COPD

10. oktober 2014 oppdatert av: Alex Jenkins, Hywel Dda Health Board

A Pilot Study to Examine the Effect of Acute Exercise on Neutrophil Function in Patients With Chronic Obstructive Pulmonary Disease

Exercise is a cornerstone of pulmonary rehabilitation in the treatment of Chronic Obstructive Pulmonary Disease (COPD). Although researchers have shown numerous benefits with exercise in COPD patients, most studies have only looked at exercise tolerance and psychological outcomes following training. COPD is characterised by persistent inflammation that can cause progressive decline in lung function and multisystemic complications. This inflammation can be amplified in patients when they suffer acute exacerbations. There is a wellknown relationship between exercise, immune function and risk of infection. Exercise has also been shown to have an antiinflammatory effect when performed regularly. There is a lack of research looking into the inflammatory or immune response to exercise in patients with COPD. The exercise within this study will be individually tailored to patients with COPD based on their validated 6 minute walk test (6MWT) but the protocol will involve interval exercise that has been used previously. This type of exercise is considered most appropriate for research into mechanisms of benefit because it maintains the exercise training effects of other modalities (e.g. continuous low intensity aerobic exercise) while avoiding the occurrence of limitations to exercise in people with lung problems (e.g. dynamic hyperinflation). It also closely mirrors daily activity of someone with COPD.

The investigators want to explore the effects of exercise specifically on immune function in 15 people COPD and compare any changes to 15 Controls. By better understanding the mechanisms of how exercise affects inflammation, the investigators could eventually design better Pulmonary Rehabilitation interventions, especially for those most at risk.

Studieoversikt

Studietype

Intervensjonell

Registrering (Faktiske)

20

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Carmarthenshire
      • Llanelli, Carmarthenshire, Storbritannia, SA14 8QF
        • Prince Philip Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

50 år til 80 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Mann

Beskrivelse

Inclusion Criteria:

  • COPD group - 15 Participants who have been diagnosed with any severity of COPD (according to BTS criteria, i.e. >10 pack-year smoking history and post-bronchodilator spirometry FEV1/FVC ratio <0.70 and FEV<80%) and have completed at least 12 from 18 sessions of a pulmonary rehabilitation programme.
  • Age 50-80 years.
  • Current non-smoker.
  • Control group - 15 Participants who will act as Controls, without COPD or cardiovascular disease
  • Age 50-80 years (ideally of similar gender distribution)
  • Current non-smoker.
  • Spirometry: FEV1/FVC>0.7 and FEV>80% predicted

Exclusion Criteria:

  • Known asthma or allergic rhinitis or other respiratory disease (bronchiectasis, pulmonary fibrosis).
  • A change in any medications within 4 weeks or during the study.
  • Require domiciliary oxygen.
  • Acute exacerbation of COPD within 4 weeks of study entry.
  • Any infection or illness within 4 weeks of study entry.
  • Other active inflammatory conditions e.g. rheumatoid arthritis, cancer, unstable cardiac conditions.
  • Receiving oral steroids or other immunomodulating drugs.
  • Currently undergoing exercise training (including Pulmonary Rehabilitation).
  • Any previous cardiovascular contraindications to exercise (e.g. unstable angina).
  • Inability to complete the 6MWT due to physical or mental impairment.
  • Exhaled CO>10ppm or smoked any cigarettes within 6 months.
  • Inability or unwillingness to sign informed consent.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Interval Exercise

Subjects will undertake an interval exercise session (on a harnessed treadmill) (HP Cosmos Mercury 4.0, HP Cosmos Sports and Medical Gmbh, Nussdorf-Traustein,Germany) based on the average speed calculated from the 6 minute walk test (6MWT).

Intervals are based on the work previously done by Mador et al., 2009 who used intervals of 150% (for 1 minute) followed by intervals of 75% (for 2 minutes) based on 80% average speed from the 6 minute walk test.

This study repeated these intervals 7 times with a duration of 23 minutes in total for the exercise intervention with the 75% intervals at the start and at the end of the exercise session. No warm up was undertaken for this method as it was a walking exercise test and the risk of injury was minimised with use of the harnessed treadmill.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Neutrophil response to exercise
Tidsramme: 4 months
The primary outcome measure for this study is to examine neutrophil responses to acute exercise, including changes in the counts and function of these cells in blood and sputa in order to compare any changes between COPD and age-gender matched controls.
4 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Different health status and the responses on neutrophil function
Tidsramme: 4 months
The secondary outcome measures for this study is to examine the responses of inflammatory (pro and anti) mediators (e.g. cytokines) to acute exercise.
4 months

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Effect of inhaled steroids on neutrophil response following exercise
Tidsramme: 4 months
The third outcome for this study is to compare neutrophil response to exercise in those taking different types of inhaled steroid (fluticasone versus budesonide or beclamethasone).
4 months
Neutrophil response to exercise in past smokers versus non-smokers
Tidsramme: 4 months
The fourth outcome measure of this study is to compare neutrophil response to exercise in past smokers versus non-smokers.
4 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Alex R Jenkins, BSc (Hons), Aberystwyth University
  • Studiestol: Keir E Lewis, MD, Hywel Dda Health Board

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. mars 2014

Primær fullføring (Faktiske)

1. juli 2014

Studiet fullført (Faktiske)

1. juli 2014

Datoer for studieregistrering

Først innsendt

7. april 2014

Først innsendt som oppfylte QC-kriteriene

24. april 2014

Først lagt ut (Anslag)

28. april 2014

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

13. oktober 2014

Siste oppdatering sendt inn som oppfylte QC-kriteriene

10. oktober 2014

Sist bekreftet

1. oktober 2014

Mer informasjon

Begreper knyttet til denne studien

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere